Prediction of overall survival and response to immune checkpoint inhibitors: An immune-related signature for gastric cancer
Gastric cancer (GC) is common in East Asia and South and Central America. Most GC patients miss the opportunities for surgery. Despite their therapeutic potential, immune checkpoint inhibitors (ICIs) only work in part of patients with GC. Thus, this study was aimed at constructing a signature for di...
Main Authors: | Zheng Wang, Xiang Li, Ying Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523321000747 |
Similar Items
-
Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanoma
by: Franziska K. Krebs, et al.
Published: (2021-03-01) -
Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
by: Ying Xu, et al.
Published: (2021-01-01) -
Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
by: Si Yang, et al.
Published: (2019-12-01) -
Development and External Validation of a Novel Immune Checkpoint–Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma
by: Enfa Zhao, et al.
Published: (2021-01-01) -
A signature of seven immune‐related genes predicts overall survival in male gastric cancer patients
by: Xin Xu, et al.
Published: (2021-02-01)